NovoSorb MTX Launch And Global Expansion Will Strengthen Future Business Prospects

Shared on01 May 25
Fair value Decreased 1.27%

Shared on24 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 5.19%

AnalystConsensusTarget has increased profit margin from 15.1% to 17.7% and decreased future PE multiple from 60.2x to 48.9x.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 4.77%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.